Evidence-Guided Hormone Care and Patient Pathways in Practice

Evidence-Guided Hormone Care and Patient Pathways

Abstract

Hello, I’m Dr. Alex Jimenez. With my diverse background as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), and Certified Functional Medicine Practitioner (CFMP, IFMCP), I have dedicated my career to a patient-centered, integrative approach to wellness. This comprehensive educational post synthesizes the latest evidence-based research and clinical insights into hormone replacement therapy. We will journey through the complexities of hormonal health, from managing menopause and optimizing testosterone to ensuring patient safety and efficacy. I will demystify common concerns such as thrombosis risk with HRT, hair loss, and the physiological effects of different hormone delivery systems. We will explore advanced diagnostic tools, the importance of clinical systems, and the art of personalizing treatment by prioritizing patient goals. Crucially, I will explain how integrative chiropractic care is woven into every aspect of this approach, addressing the foundational structural and neurological integrity that is essential for optimal hormonal balance and systemic health. This guide aims to empower both patients and practitioners with a clear, in-depth understanding of modern, holistic hormone therapy.

The Foundation of Success: Why Clinical Systems Matter

In my journey as a healthcare provider, one of the most profound lessons I’ve learned is the necessity of a robust, replicable system. Early in my career, like many practitioners, I found myself reinventing the wheel with each new patient. This approach was not only inefficient but also lacked the consistency required for truly scalable and high-quality care. It became clear that to grow and to serve our community effectively, we needed an infrastructure—a “constitution” for our practice.

This isn’t just about business growth; it’s about patient safety and efficacy. When you have a defined system, every team member, from the front desk to the clinical staff, understands their role and the patient’s journey.

• Initial Consultation: From the very first visit, the process must be clear. I ask a simple, direct question: “What are the top three things you want to fix?” Whatever those three things are, they become our primary agenda. This ensures we are aligned with the patient’s goals, which is critical for their perceived success and builds a strong foundation of trust.
• Checklists and Protocols: We utilize detailed checklists for everything, from managing potential side effects of a therapy to scheduling follow-up appointments. For any procedure, a one-week follow-up is mandatory to assess for complications like infection. This systematic approach ensures no detail is overlooked and prioritizes patient safety above all else.
• Patient Retention: A key metric of a successful system is patient engagement. Our goal is for 90% of patients to schedule their next appointment before leaving the clinic. This isn’t about just keeping the books full; it’s about ensuring continuity of care, which is vital for long-term success, especially in managing chronic or complex conditions.

This structured methodology is the bedrock upon which we build our patient relationships. It creates predictability and trust, allowing us to focus on the nuances of each individual’s health journey.

Integrative Chiropractic Care: The Structural and Neurological Core

A crucial part of our system that I want to emphasize is the role of integrative chiropractic care. The body does not operate in isolated silos. The endocrine system, which governs our hormones, is intricately connected to the nervous system. The nervous system, in turn, is housed and protected by the musculoskeletal system.

In my clinical experience, I’ve observed that spinal misalignments (subluxations) can create neurological interference, disrupting the vital communication pathways between the brain and the body’s glands, including the adrenal glands, thyroid, and ovaries. This disruption can exacerbate the symptoms of hormonal imbalance.

• Stress and the HPA Axis: Chronic physical stress from poor posture or spinal issues can activate the Hypothalamic-Pituitary-Adrenal (HPA) axis, leading to elevated cortisol. This “stress hormone” can disrupt the delicate balance of progesterone and estrogen, worsening menopausal symptoms.
• Nerve Function: Chiropractic adjustments help restore proper nerve function, optimizing the signals that regulate hormone production and release. Misalignments can interfere with the hypothalamic-pituitary-gonadal (HPG) axis, which is the central command center for sex hormone regulation. By restoring proper spinal alignment, we help normalize the function of these crucial hormonal axes.
• Holistic Assessment: As an integrative practitioner, I don’t just look at lab values. I assess the patient’s entire structure. A patient presenting with hormonal issues might also have pelvic imbalances or lower back pain that, when addressed through chiropractic care, can lead to significant improvements in their overall well-being. This creates a more favorable physiological environment for hormone therapy to be effective.

By integrating chiropractic adjustments, soft tissue therapies, and postural correction, we support the body’s innate ability to regulate itself. This structural and neurological foundation makes all other interventions, including hormone therapy, more effective.

Debunking the Myth: Hormone Replacement and Thrombosis Risk

One of the most persistent concerns I hear from patients considering hormone replacement therapy (HRT) is the fear of blood clots, or thrombosis. This fear is understandable, given historical data from older, synthetic hormone formulations. However, modern research has painted a much clearer and more reassuring picture, especially when we use bio-identical hormones and non-oral delivery methods.

A significant body of research consistently shows that when hormones are delivered transdermally (through the skin via patches, creams, or gels), the risk of thrombosis is not increased. The key difference lies in the delivery method.

• Oral Hormones: When you take a hormone pill, it passes through the digestive system and is processed by the liver in a process called “first-pass metabolism.” This process can trigger the production of certain clotting factors, which have historically been linked to an increased risk of thrombosis with oral HRT.
• Transdermal Hormones: By delivering hormones directly into the bloodstream through the skin, we bypass this first-pass metabolism. The hormones are absorbed and can go to work without stimulating the liver to produce excess clotting factors.

Numerous studies support this. A large-scale study from the UK provided powerful evidence, finding a statistically significant increased risk of deep vein thrombosis (DVT) with oral formulations but not with transdermal methods (Vinogradova et al., 2019). Meta-analyses consistently conclude there is no increased risk of blood clots with non-oral HRT (Canonico et al., 2010).

My clinical protocol is built on this evidence. For new patients, especially those with a personal or family history of clots, I always start with non-oral options. It’s the safest approach. We have these options, so it makes clinical sense to use them and eliminate that risk factor.

Progesterone Therapy: Optimizing Sleep and Endometrial Health

Progesterone is a cornerstone of therapy for my perimenopausal and menopausal patients, especially those with a uterus. Its primary role is to protect the endometrium (the lining of the uterus) from the proliferative effects of estrogen. But its benefits extend far beyond that.

The Power of Oral Progesterone for Sleep

One of the most celebrated “side effects” of oral micronized progesterone is its impact on sleep. When taken orally, progesterone is processed by the liver, and its metabolites, particularly allopregnanolone, act on GABA-A receptors in the brain. GABA (Gamma-Aminobutyric Acid) is our primary inhibitory neurotransmitter, responsible for promoting calmness and sleep.

This is a fundamentally different mechanism from other routes of administration.

• Oral Administration: Causes somnolence (drowsiness) due to first-pass hepatic metabolism, which produces sleep-promoting metabolites. This is highly desirable for women struggling with insomnia.
• Sublingual/Topical Administration: These methods bypass the liver and do not produce the same level of sleep-inducing metabolites. Therefore, giving a sublingual troche for sleep is clinically ineffective.

My standard starting dose is a 200 mg oral compounded capsule at bedtime. This dose is effective for endometrial protection and typically provides a significant benefit for sleep. I primarily use compounded progesterone to ensure a consistent, reliable dose, free of allergens such as peanut oil found in some generics.

Endometrial Health: Ultrasound and Biopsy

When managing hormone therapy, ensuring endometrial health is paramount. Any instance of abnormal or post-menopausal bleeding must be thoroughly investigated.

Our primary diagnostic tool is the transvaginal ultrasound, which allows us to measure the thickness of the endometrial lining or “stripe.”

• The Critical Cutoff: An endometrial thickness of 4 millimeters or less in a postmenopausal woman with bleeding has a 99.9% negative predictive value for endometrial cancer. This allows us to confidently adjust her hormone therapy to resolve the bleeding.

If the lining is thicker than 4-5 millimeters, the next step is an endometrial biopsy to obtain a tissue sample. The pathology results guide further treatment, ensuring we definitively rule out serious underlying conditions and prioritize patient safety.

Testosterone Therapy: A Deep Dive into Efficacy and Side Effects

Testosterone replacement therapy (TRT) is a powerful tool for restoring vitality, but its success hinges on using the right delivery method and understanding its physiological effects.

The Pitfalls of Short-Acting Testosterone Therapies

I frequently see patients who are frustrated after using transdermal creams or gels, reporting minimal improvement. The issue lies in the pharmacokinetics. These short-acting methods create a volatile “spike and trough” cycle. A patient’s level might soar to 2,000 ng/dL shortly after application, only to plummet hours later.

This volatility is problematic for two reasons:

• Adverse Events: The higher the hormonal spike, the more likely a patient is to experience side effects, such as an increase in hematocrit (red blood cell count), which can thicken the blood. This spike can also upregulate interleukin receptors, triggering an inflammatory response.
• Lack of Efficacy: The brief window of therapeutic levels means the body doesn’t receive the sustained signaling it needs to achieve consistent benefits, such as improved energy and body composition.

This is why I advocate for delivery methods that provide more stable, consistent hormone levels, such as pellets or properly timed injections, which minimize side effects and maximize efficacy.

The Initial Estrogen Spike and Red Blood Cell Response

When I start a male patient on TRT, two physiological responses almost always occur: a temporary spike in estrogen and a rise in hematocrit. It’s crucial to understand why.

• Temporary Estrogen Spike: The body uses an enzyme called aromatase to convert testosterone into estrogen. When a large amount of testosterone is introduced, aromatase goes into overdrive, causing a temporary estrogen spike. The body is a remarkable self-regulating system and will often down-regulate this enzyme over a month or two, allowing estrogen to return to a normal range. Intervening too quickly with an aromatase inhibitor can cause estrogen levels to crash, leading to joint pain, low libido, and brain fog.
• Erythropoiesis Explained: Testosterone stimulates erythropoiesis—the production of red blood cells—by signaling the kidneys to produce more erythropoietin (EPO). This increase in hemoglobin and hematocrit is a normal, dose-dependent response. If hematocrit rises too high (secondary polycythemia), it can increase blood viscosity. The good news is this is 100% dose-related and 100% reversible through dose reduction or therapeutic phlebotomy (donating blood).

Addressing Common Concerns: Hair Loss and Fertility

• Hair Loss: Male-pattern baldness is not caused by testosterone itself, but by dihydrotestosterone (DHT). A genetic predisposition is the key factor. For individuals with hair follicles genetically sensitive to DHT, an increase in testosterone can accelerate a process that is already programmed to occur. When we optimize testosterone, it can also normalize the hair growth cycle, leading to a temporary increase in shedding as old, dormant hairs are pushed out to make way for new, healthier growth.
• Fertility: External testosterone suppresses the brain’s production of LH and FSH, which shuts down sperm production. For the vast majority of men, this effect is 100% reversible once therapy is stopped, though it can take several months. For men who wish to preserve fertility while on TRT, we can use Human Chorionic Gonadotropin (hCG) to maintain testicular function.

A Concluding Thought: Your Journey to a New Normal

The art and science of medicine lie in applying evidence-based knowledge to the unique individual in front of you. The goal of hormone optimization is to restore vitality and help patients achieve a “new normal”—a state of well-being they may not have felt in years. This journey requires a partnership between a knowledgeable clinician and an engaged patient. It involves using the right therapeutic modalities to ensure stable hormone levels, addressing the whole person through an integrative framework that includes chiropractic care, and educating patients so they feel empowered in their health. By rejecting outdated protocols and embracing a modern, scientific, and holistic approach, we can safely and effectively guide our patients back to a life of energy, strength, and wellness.

References

1. Canonico, M., Plu-Bureau, G., Lowe, G. D., & Scarabin, P. Y. (2010). Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: Systematic review and meta-analysis. BMJ, 340, c2519.

2. Jimenez, A. (n.d.). Dr. Alexander Jimenez. Wellness Doctor RX. Retrieved March 28, 2026.
3. Jimenez, A. (n.d.). Alexander Jimenez DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST [LinkedIn profile]. LinkedIn. Retrieved March 28, 2026.
4. Haddad, L. M., & Sharma, S. (2023). MRSA. In StatPearls. StatPearls Publishing.
5. Koo, H. L., & DuPont, H. L. (2010). Irritable bowel syndrome: A gut and brain interaction. Indian Journal of Gastroenterology, 29(2), 55–60.
6. Patel, P., & Hashmi, M. F. (2023). Subluxation. In StatPearls. StatPearls Publishing.
7. Sizar, O., & Schwartz, J. (2023). Hypogonadism. In StatPearls. StatPearls Publishing.
8. Ramot, Y., Tiede, S., Hsi, T.-C., & Paus, R. (2017). The role of spermidine in skin and hair. Journal of the European Academy of Dermatology and Venereology, 31(10), 1628-1633.
9. Traish, A. M. (2018). Testosterone and weight loss: The evidence. Current Opinion in Endocrinology, Diabetes and Obesity, 25(5), 313–322.
10. Vinogradova, Y., Coupland, C., & Hippisley-Cox, J. (2019). Use of hormone replacement therapy and risk of venous thromboembolism: Nested case-control studies using the QResearch and CPRD databases. BMJ, 367, l6351.
11. Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Jr, Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., MacLaughlin, E. J., Muntner, P., Ovbiagele, B., Smith, S. C., Jr, Spencer, C. C., Stafford, R. S., Taler, S. J., Thomas, R. J., Williams, K. A., Sr, … Wright, J. T., Jr. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension, 71(6), e13–e115.